Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von BTIG Research 

MacroGenics Inc. diskutieren

MacroGenics Inc.

WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

1,18 €
-5,44 %

4 0
4
0

MacroGenics (NASDAQ:MGNX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for MGNX provided by MarketBeat

Zacks Research 
0
Melden Teilen
15.11.25 Buy -7,58 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

JPMorgan_Chase___Co_ in Acushnet Holdings Corp diskutieren
Acushnet (NYSE:GOLF) had its price target raised by analy...
15.12.25
Roth_Capital in Moleculin Biotech Inc diskutieren
Moleculin Biotech (NASDAQ:MBRX) had its "buy" rating rea...
15.12.25
BMO_Capital_Markets in Atco Ltd NV diskutieren
ATCO (OTCMKTS:ACLLF) had its "outperform" rating reaffir...
15.12.25
The_Goldman_Sachs_Gr in Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analy...
15.12.25
HC_Wainwright in Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price targ...
15.12.25
Evercore_ISI in Essential Properties Realty Trust diskutieren
Essential Properties Realty Trust (NYSE:EPRT) was given ...
15.12.25
Jefferies_Financial_ in Associated British Foods ADR diskutieren
Associated British Foods (OTCMKTS:ASBFY) was downgraded ...
15.12.25
Roth_Capital in Atkore International Group Inc diskutieren
Atkore (NYSE:ATKR) had its "buy" rating reaffirmed by an...
15.12.25
Mehr anzeigen